White Papers
DECENTRALISED CLINICAL TRIALS IN THE EU
STRATEGIES AND DIGITAL SOLUTIONS FOR NAVIGATING THE REGULATORY LANDSCAPE
Demystifying new Qualified Person (QP) requirements for supplying medicine in the EU and UK
European regulatory landscape: Demystifying new Qualified Person (QP) requirements for supplying medicine in the EU and UK
Clinical Trial Regulation Landscape and Decentralised Clinical Trials
EU Clinical Trial Regulation 2022: Understanding the impact on clinical research in Europe
QualTrak Workflows for mAb development
Applications for qPCR in therapeutic monoclonal antibody development and manufacturing
Enabling high-performing perfusion cell culture
Gibco CHO cell culture products for biomanufacturing
Optimize your Cell Culture Media Performance With CQREX® Ingredients
CQREX® INGREDIENTS ENSURE QUALITY, CONSISTENCY REDUCE RISKS AND IMPROVE PRODUCTIVITY
Maintaining a Drug's Bioavailability and Masking Taste With Microencapsulation
Today’s formulation challenges are as diverse as they are demanding – from increasingly insoluble new chemical entities (NCEs) to highly bitter drugs, to increased regulatory emphasis on patient acceptance – arriving at a final dosage form that has commercial potential is a more complex proposition than ever.
Pushing the Boundaries of Peptide and Oligonucleotide Purification
CONTINUOUS CHROMATOGRAPHY – PUSHING THE BOUNDARIES OF PEPTIDE AND OLIGONUCLEOTIDE PRODUCTION
Extrusion-Spheronization Engineered for Today's Controlled Release Forms
Discover How Extrusion-Spheronization Can Improve the Quality, Safety, and Efficacy of Your Oral Solid Dose Product.
How the Economy Is Updating with Biologics Manufacturing's 5,000-L Single-Use Bioreactor
Learn about the economic and operational advantages of Single-Use Bioreacctors (SUBs) for large-scale upstream bioprocessing.
